Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LYZZ Capital is a global venture capital and private equity firm founded to invest in the healthcare sector. The firm manages over $600 million in funds and has a team of experienced professionals from pharmaceutical, biotech, and financial backgrounds. With a significant presence in China for over a decade, LYZZ Capital targets investments that meet critical healthcare demands.
LYZZ Capital invests in various healthcare sectors, including medical devices, medical services, and digital health. Their investment strategy emphasizes value investing, business judgment, and market foresight to identify promising opportunities. The firm particularly seeks to address unmet medical needs in the Chinese market.
Notable portfolio companies include Chipscreen, a leader in small molecule innovative medicines in China; Alpha Biopharma, focused on global innovator drugs; and Wugen, which develops off-the-shelf cell therapies for cancer treatment. Other investments include Neurelis, MicroTech Medical, and Jumpcode Genomics.
Email your pitch deck to ir@lyzzcap.com for consideration.
LYZZ Capital often leads investment rounds, particularly in sectors where they have deep expertise and market insight.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth potential and align with their healthcare focus.
LYZZ Capital currently manages a total of $600 million across its funds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.